期刊文献+

外周血CD4^+CD25^+FOXP3^+调节性T细胞与炎症性肠病疾病活动度的关系 被引量:10

Relationship between Peripheral CD4^+ CD25^+ FOXP3^+ Regulatory T Cells and Activity of Inflammatory Bowel Disease
下载PDF
导出
摘要 背景:炎症性肠病(IBD)的发病机制尚未完全阐明.调节性T细胞是一组具有免疫抑制作用的T细胞亚群,研究显示其改变与IBD的发病密切相关.目的:观察IBD患者外周血CD4+CD25+FOXP3+调节性T细胞与疾病活动度的关系.方法:纳入克罗恩病(CD)和溃疡性结肠炎(UC)患者各31例,15例健康体检者作为正常对照.分别采用简化CD活动指数(CDAI)和临床活动度指数(CAI)评估CD和UC患者的疾病活动度,以流式细胞术检测外周血CD4+CD25+FOXP3+调节性T细胞比例,同时检测ESR和血清CRP水平.结果:CD和UC患者外周血CD4+CD25+FOXP3+调节性T细胞比例显著低于正常对照组(P〈0.05),并分别与简化CDAI评分和CAI评分呈负相关(P〈0.05),与ESR和血清CRP水平之间则无明显相关性.活动期CD和UC患者的ESR和血清CRP水平明显高于缓解期,但差异无统计学意义.ESR和CRP与疾病活动度评分之间亦无明显相关性.结论:CD4+CD25+FOXP3+调节性T细胞在IBD的发生、发展中起重要作用,外周血调节性T细胞数量减少可能是IBD复发的重要因素. Background: The pathogenesis of inflammatory bowel disease (IBD) is still not fully known. Regulatory T cells are a subgroup of T cells with immunosuppressive effect. It has been demonstrated that alterations of regulatory T cells are closely related with the development of IBD. Aims: To investigate the relationship between peripheral CD4~CD25~FOXP3* regulatory T cells and the disease activity of IBD patients. Methods: Thirty-one cases of Crohn's disease (CD), 31 ulcerative colitis (UC) and 15 healthy controls were enrolled in this study. The disease activity was scored by simplified CD activity index (CDAI) and clinical activity index (CAI) in CD and UC patients, respectively. The proportion of CD4+ CD25+FOXP3+ regulatory T cells in peripheral blood was assessed by flow eytometry; and ESR and serum CRP level were measured simultaneously. Results: The proportion of peripheral CD4+CD25+FOXP3+ regulatory T cells was significantly lower in CD and UC patients than that in healthy controls (P〈0.05). Negative correlation was found between proportion of regulatory T cells and simplified CDAI or CAI scores (P〈0.05), whereas no correlation was seen between proportion of regulatory T cells and ESR or serum CRP level. ESR and serum CRP level were higher in active CD and UC than in remission, but not of statistical significance. No correlation was seen between score of disease activity and ESR or CRP. Conclusions: CD4+CD25 +FOXP3 + regulatory T cells play a crucial role in the initiation and development of IBD. Decrease of regulatory T cells in peripheral blood might be an important factor in the recurrence of IBD.
出处 《胃肠病学》 2010年第4期218-221,共4页 Chinese Journal of Gastroenterology
基金 南京市医学科技发展项目资助(ZKX07007)
关键词 CROHN病 结肠炎 溃疡性 疾病活动度 T淋巴细胞 调节性 流式细胞术 Crohn Disease Colitis, Ulcerative Disease Activity T-Lymphocytes, Regulatory Flow Cytometry
  • 相关文献

参考文献14

  • 1Wen Z,Fiocchi C.Inflammatory bowel disease:autoimmune or immune-mediated pathogenesis? Clin Dev Immunol,2004,11 (3-4):195-204. 被引量:1
  • 2Maul J,Loddenkemper C,Mundt P,et al.Peripheral and intestinal regulatory CD4 + CD25 (high) T cells in inflammatory bowel disease.Gastroenterology,2005,128 (7):1868-1878. 被引量:1
  • 3Saruta M,Yu QT,Fleshner PR,et al.Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.Clin Immunol,2007,125 (3):281-290. 被引量:1
  • 4Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3.Science,2003,299 (5609):1057-1061. 被引量:1
  • 5欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 6Rachmilewitz D.Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis:a randomised trial.BMJ,1989,298 (6666):82-86. 被引量:1
  • 7Annunziato F,Cosmi L,Santarlasci V,et al.Phenotypic and functional features of human Th17 cells.J Exp Med,2007,204 (8):1849-1861. 被引量:1
  • 8Mottet C,Uhlig HH,Powrie F.Cutting edge:cure of colitis by CD4+CD25+ regulatory T cells.J Immunol,2003,170 (8):3939-3943. 被引量:1
  • 9Powrie F.Immune regulation in the intestine:a balancing act between effector and regulatory T cell responses.Ann N Y Acad Sci,2004,1029:132-141. 被引量:1
  • 10Maloy KJ,Salaun L,Cahill R,et al.CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.J Exp Med,2003,197 (1):111-119. 被引量:1

二级参考文献18

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247. 被引量:5
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154. 被引量:3
  • 3Ouyang Q,Tandon R,Goh KL,et al.The emergence of inflammatory bowel disease in the Asian Pacific region.Curr Opin Gastroenterol,2005,21 (4):408-413. 被引量:1
  • 4Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease:controversies,consensus,and implications.Gut,2006,55(6):749-753. 被引量:1
  • 5Kornbluth A,Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults (update):American College of Gastroenterology,Practice Parameters Committee.Am J Gastroenterol,2004,99 (7):1371-1385. 被引量:1
  • 6Hanauer SB,Sandborn W; Practice Parameters Committee of the American College of Gastroenterology.Management of Crohn's disease in adults.Am J Gastroenterol,2001,96 (3):635-643. 被引量:1
  • 7Stange EF,Travis SP,Vermeire S,et al.European Crohn's and Colitis Organisation.European evidence based consensus on the diagnosis and management of Crohn's disease:definitions and diagnosis.Gut,2006,55Suppl 1:i1-i15. 被引量:1
  • 8Carter MJ,Lobo AJ,Travis SP; IBD Section,British Society of Gastroenterology.Guidelines for the management of inflammatory bowel disease in adults.Gut,2004,53 Suppl 5:V1-V16. 被引量:1
  • 9Shivananda S,Hordijk ML,Ten Kate FJ,et al.Differential diagnosis of inflammatory bowel disease.A comparison of various diagnostic classifications.Scand J Gastroenterol,1991,26 (2):167-173. 被引量:1
  • 10樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278. 被引量:3

共引文献750

同被引文献78

引证文献10

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部